Drug resistance mutations to integrase inhibitors, proteinase, and reverse transcriptase inhibitors in newly diagnosed HIV-1 infections in Hebei province, China, 2018-2022.
- DOI
- 10.3389/fcimb.2025.1510916
- Published
- 2025
- Container
- Frontiers in cellular and infection microbiology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fcimb.2025.1510916,
title = {Drug resistance mutations to integrase inhibitors, proteinase, and reverse transcriptase inhibitors in newly diagnosed HIV-1 infections in Hebei province, China, 2018-2022.},
author = {Lu X and Li Y and Liu M and Wang Y and An N and Sun D and Li Q},
year = {2025},
journal = {Frontiers in cellular and infection microbiology},
doi = {10.3389/fcimb.2025.1510916},
url = {https://doi.org/10.3389/fcimb.2025.1510916}
}RIS
TY - JOUR TI - Drug resistance mutations to integrase inhibitors, proteinase, and reverse transcriptase inhibitors in newly diagnosed HIV-1 infections in Hebei province, China, 2018-2022. AU - Lu X AU - Li Y AU - Liu M AU - Wang Y AU - An N AU - Sun D AU - Li Q PY - 2025 JO - Frontiers in cellular and infection microbiology DO - 10.3389/fcimb.2025.1510916 UR - https://doi.org/10.3389/fcimb.2025.1510916 ER -
APA
X, L., Y, L., M, L., Y, W., N, A., D, S., & Q, L. (2025). Drug resistance mutations to integrase inhibitors, proteinase, and reverse transcriptase inhibitors in newly diagnosed HIV-1 infections in Hebei province, China, 2018-2022.. Frontiers in cellular and infection microbiology. https://doi.org/10.3389/fcimb.2025.1510916
Source records
- pubmed · retrieved 2026-11-10T10:55:13.950Z